Skip to main content
. 2018 Aug 31;2018(8):CD008831. doi: 10.1002/14651858.CD008831.pub3

Theodoropoulos 2013.

Methods Single‐centre double‐blind RCT
Participants Participants underwent colectomy for cancer
No mention of participants undergoing chemotherapy or radiotherapy
Interventions Synbiotics (combination of prebiotics and probiotics) (n = 38)
Placebo (n = 35)
Administration at the day participants were able to tolerate PO liquid diet and for 15 days thereafter
Outcomes Primary endpoints: gastrointestinal function‐related quality of life at 1, 3, and 6 months postoperatively (using validated questionnaire GIQLI (Gastrointestinal Quality of Life Index))
Secondary endpoints: assessment of functional bowel disorders (diarrhoea, constipation) based on respective domains of the validated instrument EORTC‐QLQ‐C30
Notes Clintrial.Gov trial ID NCT01479907
No mention of participants undergoing chemotherapy or radiotherapy
 Trial may be excluded in a future update

EORTC‐QLQ‐C30: questionnaire developed to assess the quality of life of patients with cancer, version 3.

GIQLI: Gastrointestinal Quality of Life Index.

PO: by mouth.

RCT: randomised controlled trial.